SCHEMBL854495

SCHEMBL854495

CCOC(=O)C=C(c1cnc2ccccc2c1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 5/20 0.35
MAOB P27338 1/20 0.34
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33
KDR P35968 1/20 0.31
HTT P42858 1/20 0.31
GABRA1 P14867 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853915 0.92 HTT (0.35) MTNR1AMTNR1BHTTMEN1KMT2A
SCHEMBL852464 0.82 NR4A2 (0.36) MTNR1AMTNR1BKDRMEN1KMT2A
SCHEMBL853983 0.80 ITGB3 (0.35) CCKBRMTNR1AMTNR1BGABRA1GABRG2
SCHEMBL860800 0.80 MAOB (0.35) MAOBMAPT
SCHEMBL853670 0.75 NR1H2 (0.36) MTNR1AMTNR1BHTTMEN1KMT2A
SCHEMBL854074 0.71 ITGB3 (0.39) MEN1KMT2A
SCHEMBL861190 0.71 MAOA (0.42) MTNR1AMTNR1B
SCHEMBL861638 0.69 ITGB3 (0.51)
SCHEMBL853770 0.68 NR1H2 (0.36) MTNR1AMTNR1BMEN1KMT2ALMNA
SCHEMBL853558 0.66 TRPM8 (0.55) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed